Epidemiology of Neuropathic Pain and Its Impact on Quality of Life

Epidemiology is an important clinical tool in designing and evaluating management and prevention strategies, and is particularly relevant to neuropathic pain. However, there is a relative lack of accurate information available. In one sense, neuropathic pain describes a symptom or a mechanism, rathe...

Full description

Saved in:
Bibliographic Details
Published in:Current pain and headache reports 2012-06, Vol.16 (3), p.191-198
Main Authors: Smith, Blair H., Torrance, Nicola
Format: Article
Language:English
Subjects:
Austria - epidemiology
Canada - epidemiology
Chronic Pain - economics
Chronic Pain - epidemiology
Chronic Pain - psychology
Cost of Illness
Diabetic neuropathy
Epidemiology
Female
France - epidemiology
Health Behavior
Humans
Internal Medicine
Male
Medicine
Medicine & Public Health
Netherlands - epidemiology
Neuralgia - economics
Neuralgia - epidemiology
Neuralgia - psychology
Neuropathic Pain (R Raja
Pain
Pain Measurement - methods
Pain Medicine
Patient Education as Topic - economics
Quality of Life
Risk Factors
Section editor
Socioeconomic Factors
United Kingdom - epidemiology
United States - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Epidemiology is an important clinical tool in designing and evaluating management and prevention strategies, and is particularly relevant to neuropathic pain. However, there is a relative lack of accurate information available. In one sense, neuropathic pain describes a symptom or a mechanism, rather than a specific disease; on the other hand, there are sufficient similarities in the effects and response to treatment between different causes to make it worthwhile to consider neuropathic pain as a distinct condition. However, there are important specific disease-based factors that need to be considered separately. Estimates of prevalence that are based on specific causes of neuropathic pain tend to be lower (1–2%) than those that are based on reports of the classic symptoms (6–8%), and further methodological research is needed. All neuropathic pain is associated with poor general health, comparable with other severe chronic diseases. The importance of newly proposed risk factors, including genetic factors, still needs to be assessed at a population level.
ISSN:1531-3433
1534-3081
DOI:10.1007/s11916-012-0256-0